Bioequivalence Study of Sitagliptin/Metformin Extended-Release Tablets in Healthy Subjects

Study Finds GLP-1 Drug Users Show Decreased Physical Activity Levels

A new study presented by doctors at HSHS Saint John's Hospital in Illinois found that people taking GLP-1 drugs like Ozempic and Wegovy sign

AI Analysis of Reddit Posts Identifies Potential Side Effects of GLP-1 Weight Loss Drugs

Researchers at the University of Pennsylvania used AI to analyze over 410,000 Reddit posts spanning six years to identify potential side eff

Kailera’s oral GLP-1 asset sees 11% weight loss, hits goals in Chinese phase 3 obesity and diabetes trials

A salute to innovation: exenatide in diabetes and obesity drug development at Amylin Pharmaceuticals - Nature Metabolism

Conflicts of interest threaten integrity of GLP-1 therapy guidance amid rapid adoption

This article discusses the rapid uptake and commercial success of GLP-1 receptor agonists for obesity management, highlighting their clinica

Study: GLP-1 Weight Loss Drugs Linked to Decline in Daily Physical Activity

A new study analyzing NIH All of Us Research Program data, including Fitbit activity records and electronic health records, reveals that adu